Current studies
Adults
| Sponsor | Study | Target population | Status |
| CIHR (CHU de Québec) | COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases (COVBIRD) | Adults with a systemic autoimmune rheumatic disease | Recruiting |
| CIHR (DrCaroline Quach) | RECOVER: REinfection in COVID-19 Estimation of Risk: extension | Health Care Workers who have had COVID-19 | Recruiting |
| MSSS funds (Dr Ines Colmegna) | COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases (COVIAAD) | Adults with rheumatic diseases | Recruitment closed |
| Medicago | SARS-CoV-2 vaccine (Phase 2 & 3) | 18 and older | Recruitment closed |
Pediatrics
| Sponsor | Study | Target population | Status |
| Merck | Monoclonal antibody against Respiratory Syncytial Virus (RSV) | Infants | Recruiting |
| CIRN network | Special Immunization Clinic | Children until 17 yo | Recruiting |
| MedImmune | Monoclonal antibody against Respiratory Syncytial Virus (RSV) | Infants | Recruitment closed |
| Pfizer | Pneumococcal vaccine (Phase 3) | Infants | Recruitment closed |
| Moderna | SARS-CoV-2 vaccine (Phase 3) | 6mo to 12yrs | Recruitment closed |